Intravascular Ultrasound-Guided PCI in Patients With Chronic Kidney Disease

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorFirst Affiliated Hospital Xi'an Jiaotong University

About this trial

The IVUS-CKD study is a prospective, randomized controlled, multicenter trial to determine whether the intravascular ultrasound (IVUS)-guided percutaneous coronary intervention is superior to the angiography-guidance in chronic kidney disease (CKD) patients with respect to target vessel failure (TVF) at 12 months after randomization.

Eligibility criteria

Qualifiers

CKD patients with eGFR<60 mL/min/1.73 m²

De novo coronary lesion suitable for second-generation metallic drug-eluting stent placement and IVUS imaging

Signed written informed consent

Disqualifiers

Onset of STEMI within 24 hours or emergent angiography

Pregnant or childbearing women

Co-morbidity with an estimated life expectancy of < 1 year

LVEF ≤ 30%

Trial design

Treatments tested in this trial

  • Percutaneous coronary intervention

Treatment groups

1,528 Participants
are divided into 2 treatment groups